Helping Behavior, Help-Seeking Behavior, Relationship, Social, Sexual Assault, Sexual Violence, Social Interaction, Stress, Stress Disorders, Post-Traumatic
Conditions
Brief summary
Communication and Recovery Enhancement (CARE) is a 2-session early intervention for survivors of recent sexual assault and their supporters that aims to improve supporters' ability to respond effectively. The goal of this pilot trial is to understand the acceptability and preliminary efficacy of two versions of CARE: a version in which survivors and supporters attend both sessions together (dyadic CARE) and a version in which supporters attend sessions alone (supporter-only CARE). Survivors aged 14+ with elevated posttraumatic stress symptoms will enroll with a supporter of their choosing. Dyads will be randomized to dyadic CARE, supporter-only CARE, or waitlist control, and will complete self-report assessments at baseline, post-session-1, and follow-ups (1, 2, and 3 months post-baseline). Results will be used to inform future changes to CARE and determine whether a fully-powered randomized controlled trial is warranted.
Interventions
BEHAVIORALDyadic CARE
Dyadic CARE involves two telehealth sessions with a clinician, the survivor, and a supporter of the survivor's choice. Session content uses cognitive-behavioral strategies (e.g., encouraging non-avoidance) to encourage communication and improve supporters' responses in trauma-related conversations. Between sessions, both the survivor and the supporter are instructed to review session content and have guided discussions with the assistance of a workbook.
BEHAVIORALSupporter-Only CARE
Supporter-only CARE involves two telehealth sessions with a clinician and a supporter of the survivor's choice, without the survivor present. Session content uses cognitive-behavioral strategies (e.g., encouraging non-avoidance) to encourage communication and improve supporters' responses in trauma-related conversations. Between sessions, both the survivor and the supporter are instructed to review session content and have guided discussions with the assistance of a workbook.
Sponsors
University of Washington
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(Survivors): * Age 14+ years * Can speak/read English or Spanish * Have access to a Zoom-capable device * Screened for eligibility within 10 weeks of sexual assault, defined as any unwanted, distressing sexual contact (e.g., unwanted touching, coerced sexual activity, rape) * Able to attend first study session within 2 weeks of screening * Elevated PTSD symptoms at screening as operationalized by a Primary Care PTSD Screen score of 2/5 or above * Able to identify an eligible supporter * Have a way to receive survey links and complete surveys privately (i.e., without potential device or account access by the supporter) Inclusion Criteria (Supporters): * Age 14+ years * Can speak/read English or Spanish * Have access to a Zoom-capable device * Able to attend first study session within 2 weeks of survivor's screening * Are in contact with the survivor at least once a week * In the opinion of the survivor, are able to make an independent decision about whether or not to participate in the study * Have a way to receive survey links and complete surveys privately (i.e., without potential device or account access by the survivor)
Exclusion criteria
(Survivors): * Active psychosis * Active suicidal intent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Survivor Stress at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater stress. |
| Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report) | 3 months | Provisional PTSD diagnostic status based on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Survivors will be considered to have a provisional diagnosis if the following items are rated as 2 = Moderately or higher: one Criterion B item (questions 1-5), one Criterion C item (questions 6-7), two Criterion D items (questions 8-14), and two Criterion E items (questions 15-20). |
| Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Range: 0-80; higher scores indicate greater severity of PTSD symptoms. |
| Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report) | Baseline & 1 month | Sum score on the Responsiveness subscale of the Perceived Responsiveness and Insensitivity scale, completed by survivor in reference to past month. Range: 0 to 40; higher scores indicate greater responsiveness. |
| Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 1 month | Sum score on Unsupportive Acknowledgment subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent subtly unsupportive reactions. |
| Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 1 month | Sum score on Turning Against subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent hostile negative reactions. |
| Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report) | 1 month | Single item representing frequency of disclosures to supporter in past month, completed by survivor, adapted from the Early Intervention Clinic Disclosure scale. Survivor will input a numerical response representing number of disclosures. Higher scores indicate more frequent disclosure. |
| Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report) | Baseline, 1 month | Sum score on the Confusion subscale of the Impact on Friends scale, completed by supporter. Range: 6 to 30; higher scores indicate greater confusion about helping behavior. |
| Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report) | Baseline, 1 month | Sum score on 4-item measure created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater confusion. |
| Change in Supporter Knowledge at 1 Month Post-baseline (Self Report) | Baseline, 1 month | Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the supporter. Range: 9 to 45; higher scores indicate more knowledge about CARE concepts. |
| Change in Survivor Knowledge at 1 Month Post-baseline (Self Report) | Baseline, 1 month | Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the survivor. Range: 8 to 40; higher scores indicate more knowledge about CARE concepts. |
| Supporter Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 1 month | Sum score on Client Satisfaction Scale, completed by supporter. Range: 8 to 32; higher scores indicate greater satisfaction |
| Survivor Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 1 month | Sum score on Client Satisfaction Scale, completed by survivor. Range: 8 to 32; higher scores indicate greater satisfaction |
| Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Relationship Assessment Scale, completed by supporter. Range: 7 to 35; higher scores indicate greater relationship quality. |
| Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Relationship Assessment Scale, completed by survivor. Range: 7 to 35; higher scores indicate greater relationship quality. |
| Change in Supporter Stress at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater stress. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report) | 1 month | Sum score on the Confusion subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 6 to 30; higher scores indicate greater perceived ineffectiveness. |
| Supporter Distress in Helping at 1 Month Post-baseline (Self Report) | 1 month | Sum score on the Emotional Distress subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 24 to 120; higher scores indicate greater distress. |
| Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report) | 1 month | Sum score on the Significant Others' Responses to Trauma Scale (SORTS), completed by supporter in reference to the past month. Range: 0 to 112; higher scores indicate greater accommodation. |
| Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of cannabis use in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Change in Survivor Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 1 month | Sum score score on measure created for this study, completed by survivor. Range: 0 to 10; higher scores indicate greater willingness. |
| Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 1 month | Mean score on measure created for this study, completed by survivor. Range: 0 to 1; higher scores indicate greater participation. |
| Change in Survivor Depression at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater depression. |
| Change in Supporter Depression at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater depression. |
| Change in Survivor Anxiety at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety. |
| Change in Supporter Anxiety at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety. |
| Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on Work/School/Responsibility Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment. |
| Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on Social Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment. |
| Change in Survivor Flourishing at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on Flourishing Index Measure, completed by survivor. Range: 0 to 120; higher scores indicate more flourishing. |
| Change in Supporter Flourishing at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Sum score on Flourishing Index Measure, completed by supporter. Range: 0 to 120; higher scores indicate more flourishing. |
| Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report) | 1 month | Mean score on ratings of distress associated endorsed items on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions to survivor in past month. Range: 0 to 3; higher scores indicate more distress. |
| Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 1 month | Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions. |
| Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinks per week in past month reported by survivor on the Daily Drinking Questionnaire |
| Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinking days per week in past month reported by survivor on the Daily Drinking Questionnaire. Range: 0 to 7. |
| Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinking hours per week in past month reported by survivor on the Daily Drinking Questionnaire. |
| Change in Survivor Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of non-prescription opioid use in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of methamphetamine use in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of cigarette use in past 2 weeks, as reported by survivor. Range: 0 to 14. |
| Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of cigarettes smoked in a typical day in past 2 weeks, as reported by survivor. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 1 month | Sum score on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 48; higher scores indicate more frequent negative reactions. |
| Change in Supporter Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of cigarettes smoked in a typical day in past 2 weeks, as reported by supporter. |
| Change in Supporter Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of cigarette use in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of methamphetamine use in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of non-prescription opioid use in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of days of cannabis use in past 2 weeks, as reported by supporter. Range: 0 to 14. |
| Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinking hours per week in past month reported by supporter on the Daily Drinking Questionnaire. |
| Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinking days per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7. |
| Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | Baseline, 3 months | Number of typical drinks per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7. |
| Supporter Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 1 month | Sum score on survey created for this study, completed by supporter. Range: 4 to 20; higher scores indicate greater perceived impact of intervention. |
| Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report) | 1 month | Single item representing frequency of survivor's disclosures to supporter in past month, completed by supporter, adapted from the Early Intervention Clinic Disclosure Scale. Participants were instructed to enter a numerical value corresponding to number of disclosures. Higher scores indicate more frequent disclosure. |
| Survivor Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 1 month | Sum score on survey created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater perceived impact of intervention. |
| Supporter Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 1 month | Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention. |
| Survivor Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 1 month | Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention. |
| Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 1 month | Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Dyadic CARE (Survivors) Survivors randomized to receive dyadic CARE (both dyad members attended both sessions and completed a workbook together) | 21 |
| Supporter-Only CARE (Survivors) Survivors randomized to receive supporter-only CARE (only the supporter attended both sessions; the dyad completed a workbook together) | 22 |
| Waitlist Control (Survivors) Survivors randomized to receive waitlist CARE (invited to complete the CARE version of their choice following the completion of study measures) | 21 |
| Dyadic CARE (Supporters) Supporters randomized to receive dyadic CARE (both dyad members attended both sessions and completed a workbook together) | 21 |
| Supporter-Only CARE (Supporters) Supporters randomized to receive supporter-only CARE (only the supporter attended both sessions; the dyad completed a workbook together) | 22 |
| Waitlist Control (Supporters) Supporters randomized to receive waitlist CARE (invited to complete the CARE version of the survivor's choice following the completion of study measures) | 21 |
| Total | 128 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 | FG002 |
|---|---|---|---|---|
| Overall Study | Did not meet eligibility criteria | 0 | 2 | 0 |
| Overall Study | Lost to Follow-up | 0 | 0 | 1 |
| Overall Study | Withdrawal by Subject | 2 | 0 | 0 |
Baseline characteristics
| Characteristic | Waitlist Control (Supporters) | Total | Dyadic CARE (Survivors) | Supporter-Only CARE (Survivors) | Waitlist Control (Survivors) | Dyadic CARE (Supporters) | Supporter-Only CARE (Supporters) |
|---|---|---|---|---|---|---|---|
| Age, Continuous | 30.80 Years STANDARD_DEVIATION 11.87 | 29.33 Years STANDARD_DEVIATION 11.69 | 26.48 Years STANDARD_DEVIATION 9.56 | 23.24 Years STANDARD_DEVIATION 6.07 | 25.52 Years STANDARD_DEVIATION 9.32 | 32.48 Years STANDARD_DEVIATION 10.75 | 37.52 Years STANDARD_DEVIATION 15.38 |
| Ethnicity (NIH/OMB) Hispanic or Latino | 18 Participants | 66 Participants | 4 Participants | 5 Participants | 4 Participants | 17 Participants | 18 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 3 Participants | 60 Participants | 17 Participants | 16 Participants | 17 Participants | 4 Participants | 3 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 1 Participants | 0 Participants | 1 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 4 Participants | 30 Participants | 5 Participants | 6 Participants | 4 Participants | 5 Participants | 6 Participants |
| Race (NIH/OMB) Black or African American | 1 Participants | 4 Participants | 1 Participants | 0 Participants | 0 Participants | 2 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 14 Participants | 5 Participants | 3 Participants | 3 Participants | 2 Participants | 1 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 3 Participants | 18 Participants | 3 Participants | 3 Participants | 2 Participants | 3 Participants | 4 Participants |
| Race (NIH/OMB) White | 13 Participants | 59 Participants | 7 Participants | 8 Participants | 12 Participants | 9 Participants | 10 Participants |
| Sex: Female, Male Female | 16 Participants | 102 Participants | 19 Participants | 18 Participants | 20 Participants | 13 Participants | 16 Participants |
| Sex: Female, Male Male | 5 Participants | 23 Participants | 1 Participants | 3 Participants | 1 Participants | 8 Participants | 5 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk | EG002 affected / at risk | EG003 affected / at risk | EG004 affected / at risk | EG005 affected / at risk |
|---|---|---|---|---|---|---|
| deaths Total, all-cause mortality | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 |
| other Total, other adverse events | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 |
| serious Total, serious adverse events | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 | 0 / 21 |
Outcome results
Primary
Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report)
Sum score on the Confusion subscale of the Impact on Friends scale, completed by supporter. Range: 6 to 30; higher scores indicate greater confusion about helping behavior.
Time frame: Baseline, 1 month
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report) | -4.35 score on a scale | Standard Deviation 3.88 |
| Supporter-Only CARE (Survivors) | Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report) | -3.70 score on a scale | Standard Deviation 3.42 |
| Waitlist Control (Survivors) | Change in Supporter Confusion About Helping Behavior at 1 Month Post-baseline (Self Report) | -1.85 score on a scale | Standard Deviation 3.23 |
Primary
Change in Supporter Knowledge at 1 Month Post-baseline (Self Report)
Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the supporter. Range: 9 to 45; higher scores indicate more knowledge about CARE concepts.
Time frame: Baseline, 1 month
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Knowledge at 1 Month Post-baseline (Self Report) | 4.61 Points | Standard Deviation 2.93 |
| Supporter-Only CARE (Survivors) | Change in Supporter Knowledge at 1 Month Post-baseline (Self Report) | 4.84 Points | Standard Deviation 3.55 |
| Waitlist Control (Survivors) | Change in Supporter Knowledge at 1 Month Post-baseline (Self Report) | 0.33 Points | Standard Deviation 2.54 |
Primary
Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report)
Sum score on the Relationship Assessment Scale, completed by supporter. Range: 7 to 35; higher scores indicate greater relationship quality.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | 0.35 score on a scale | Standard Deviation 3.94 |
| Supporter-Only CARE (Survivors) | Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | 0.39 score on a scale | Standard Deviation 2 |
| Waitlist Control (Survivors) | Change in Supporter Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | -2.10 score on a scale | Standard Deviation 4.33 |
Primary
Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report)
Sum score on the Responsiveness subscale of the Perceived Responsiveness and Insensitivity scale, completed by survivor in reference to past month. Range: 0 to 40; higher scores indicate greater responsiveness.
Time frame: Baseline & 1 month
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report) | -2.21 score on a scale | Standard Deviation 5.9 |
| Supporter-Only CARE (Survivors) | Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report) | -0.10 score on a scale | Standard Deviation 7.49 |
| Waitlist Control (Survivors) | Change in Supporter Responsiveness at 1 Month Post-baseline (Informant Report) | 0.14 score on a scale | Standard Deviation 8.24 |
Primary
Change in Supporter Stress at 3 Months Post-baseline (Self Report)
Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater stress.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Stress at 3 Months Post-baseline (Self Report) | -2.15 score on a scale | Standard Deviation 3.3 |
| Supporter-Only CARE (Survivors) | Change in Supporter Stress at 3 Months Post-baseline (Self Report) | -1.22 score on a scale | Standard Deviation 3.32 |
| Waitlist Control (Survivors) | Change in Supporter Stress at 3 Months Post-baseline (Self Report) | -0.65 score on a scale | Standard Deviation 3.07 |
Primary
Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report)
Sum score on 4-item measure created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater confusion.
Time frame: Baseline, 1 month
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report) | -2.21 score on a scale | Standard Deviation 4.04 |
| Supporter-Only CARE (Survivors) | Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report) | -1.14 score on a scale | Standard Deviation 3.64 |
| Waitlist Control (Survivors) | Change in Survivor Confusion About Help-seeking Behavior at 1 Month Post-baseline (Self Report) | 0.86 score on a scale | Standard Deviation 4.5 |
Primary
Change in Survivor Knowledge at 1 Month Post-baseline (Self Report)
Sum score on a knowledge questionnaire reflecting CARE concepts, completed by the survivor. Range: 8 to 40; higher scores indicate more knowledge about CARE concepts.
Time frame: Baseline, 1 month
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Knowledge at 1 Month Post-baseline (Self Report) | 3.24 score on a scale | Standard Deviation 3.7 |
| Supporter-Only CARE (Survivors) | Change in Survivor Knowledge at 1 Month Post-baseline (Self Report) | 0.20 score on a scale | Standard Deviation 3.47 |
| Waitlist Control (Survivors) | Change in Survivor Knowledge at 1 Month Post-baseline (Self Report) | 0.61 score on a scale | Standard Deviation 4.75 |
Primary
Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report)
Sum score on the Relationship Assessment Scale, completed by survivor. Range: 7 to 35; higher scores indicate greater relationship quality.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | -0.39 score on a scale | Standard Deviation 2.5 |
| Supporter-Only CARE (Survivors) | Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | -1.60 score on a scale | Standard Deviation 4.45 |
| Waitlist Control (Survivors) | Change in Survivor Perceived Relationship Quality at 3 Months Post-baseline (Self Report) | -1.76 score on a scale | Standard Deviation 4.12 |
Primary
Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report)
Sum score on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Range: 0-80; higher scores indicate greater severity of PTSD symptoms.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report) | -12.12 score on a scale | Standard Deviation 17.54 |
| Supporter-Only CARE (Survivors) | Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report) | -16.58 score on a scale | Standard Deviation 13.32 |
| Waitlist Control (Survivors) | Change in Survivor PTSD Symptom Severity at 3 Months Post-baseline (Self Report) | -16.25 score on a scale | Standard Deviation 13.32 |
Primary
Change in Survivor Stress at 3 Months Post-baseline (Self Report)
Sum score on the Stress subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater stress.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Stress at 3 Months Post-baseline (Self Report) | -1.66 score on a scale | Standard Deviation 5.39 |
| Supporter-Only CARE (Survivors) | Change in Survivor Stress at 3 Months Post-baseline (Self Report) | -2.42 score on a scale | Standard Deviation 3.56 |
| Waitlist Control (Survivors) | Change in Survivor Stress at 3 Months Post-baseline (Self Report) | -1.38 score on a scale | Standard Deviation 3.58 |
Primary
Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report)
Sum score on Turning Against subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent hostile negative reactions.
Time frame: 1 month
Population: Only assessed among survivors reporting past-month disclosure to the supporter
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 1.41 score on a scale | Standard Error 0.53 |
| Supporter-Only CARE (Survivors) | Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 2.96 score on a scale | Standard Error 0.49 |
| Waitlist Control (Survivors) | Supporter Overt Hostile Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 2.49 score on a scale | Standard Error 0.5 |
Primary
Supporter Satisfaction With Intervention at 1 Month Post-baseline (Self Report)
Sum score on Client Satisfaction Scale, completed by supporter. Range: 8 to 32; higher scores indicate greater satisfaction
Time frame: 1 month
Population: 2 participants did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 29.79 score on a scale | Standard Deviation 2.65 |
| Supporter-Only CARE (Survivors) | Supporter Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 29.60 score on a scale | Standard Deviation 2.28 |
Primary
Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report)
Sum score on Unsupportive Acknowledgment subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 24; higher scores indicate more frequent subtly unsupportive reactions.
Time frame: 1 month
Population: Only assessed among survivors reporting past-month disclosure to the supporter
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 2.04 score on a scale | Standard Error 0.57 |
| Supporter-Only CARE (Survivors) | Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 2.23 score on a scale | Standard Error 0.52 |
| Waitlist Control (Survivors) | Supporter Subtly Unsupportive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 3.34 score on a scale | Standard Error 0.54 |
Primary
Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report)
Single item representing frequency of disclosures to supporter in past month, completed by survivor, adapted from the Early Intervention Clinic Disclosure scale. Survivor will input a numerical response representing number of disclosures. Higher scores indicate more frequent disclosure.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report) | 2.67 number of disclosures | Standard Error 0.21 |
| Supporter-Only CARE (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report) | 3.02 number of disclosures | Standard Error 0.21 |
| Waitlist Control (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Self Report) | 2.66 number of disclosures | Standard Error 0.21 |
Primary
Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report)
Provisional PTSD diagnostic status based on PTSD Checklist-5 (PCL-5), completed by survivor in reference to past month. Survivors will be considered to have a provisional diagnosis if the following items are rated as 2 = Moderately or higher: one Criterion B item (questions 1-5), one Criterion C item (questions 6-7), two Criterion D items (questions 8-14), and two Criterion E items (questions 15-20).
Time frame: 3 months
Population: Participants were excluded if they did not complete the scale at 3 months post baseline
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Dyadic CARE (Survivors) | Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report) | 8 Participants |
| Supporter-Only CARE (Survivors) | Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report) | 5 Participants |
| Waitlist Control (Survivors) | Survivor Provisional PTSD Diagnostic Status at 3 Months Post-baseline (Self Report) | 9 Participants |
Primary
Survivor Satisfaction With Intervention at 1 Month Post-baseline (Self Report)
Sum score on Client Satisfaction Scale, completed by survivor. Range: 8 to 32; higher scores indicate greater satisfaction
Time frame: 1 month
Population: 2 participants did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 28.37 score on a scale | Standard Deviation 3.39 |
| Supporter-Only CARE (Survivors) | Survivor Satisfaction With Intervention at 1 Month Post-baseline (Self Report) | 27.71 score on a scale | Standard Deviation 3.51 |
Secondary
Change in Supporter Anxiety at 3 Months Post-baseline (Self Report)
Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Anxiety at 3 Months Post-baseline (Self Report) | 0.33 score on a scale | Standard Deviation 1.53 |
| Supporter-Only CARE (Survivors) | Change in Supporter Anxiety at 3 Months Post-baseline (Self Report) | 1.00 score on a scale | Standard Deviation 2.51 |
| Waitlist Control (Survivors) | Change in Supporter Anxiety at 3 Months Post-baseline (Self Report) | 0.33 score on a scale | Standard Deviation 1.53 |
Secondary
Change in Supporter Depression at 3 Months Post-baseline (Self Report)
Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by supporter in reference to past week. Range: 0 to 21; higher scores indicate greater depression.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Depression at 3 Months Post-baseline (Self Report) | -0.80 score on a scale | Standard Deviation 2.88 |
| Supporter-Only CARE (Survivors) | Change in Supporter Depression at 3 Months Post-baseline (Self Report) | -0.72 score on a scale | Standard Deviation 2.02 |
| Waitlist Control (Survivors) | Change in Supporter Depression at 3 Months Post-baseline (Self Report) | 0.44 score on a scale | Standard Deviation 4.05 |
Secondary
Change in Supporter Flourishing at 3 Months Post-baseline (Self Report)
Sum score on Flourishing Index Measure, completed by supporter. Range: 0 to 120; higher scores indicate more flourishing.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Flourishing at 3 Months Post-baseline (Self Report) | 1.65 score on a scale | Standard Deviation 10.39 |
| Supporter-Only CARE (Survivors) | Change in Supporter Flourishing at 3 Months Post-baseline (Self Report) | 5.22 score on a scale | Standard Deviation 9.52 |
| Waitlist Control (Survivors) | Change in Supporter Flourishing at 3 Months Post-baseline (Self Report) | -7.33 score on a scale | Standard Deviation 17.39 |
Secondary
Change in Survivor Anxiety at 3 Months Post-baseline (Self Report)
Sum score on the Anxiety subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater anxiety.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Anxiety at 3 Months Post-baseline (Self Report) | -1.53 score on a scale | Standard Deviation 4.5 |
| Supporter-Only CARE (Survivors) | Change in Survivor Anxiety at 3 Months Post-baseline (Self Report) | -1.50 score on a scale | Standard Deviation 3.22 |
| Waitlist Control (Survivors) | Change in Survivor Anxiety at 3 Months Post-baseline (Self Report) | -2.10 score on a scale | Standard Deviation 5.4 |
Secondary
Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of cannabis use in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | -0.11 Days | Standard Deviation 1.79 |
| Supporter-Only CARE (Survivors) | Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | 0.63 Days | Standard Deviation 2.39 |
| Waitlist Control (Survivors) | Change in Survivor Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | -1.62 Days | Standard Deviation 2.91 |
Secondary
Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of cigarette use in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | -0.05 Days | Standard Deviation 0.23 |
| Supporter-Only CARE (Survivors) | Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | -0.16 Days | Standard Deviation 0.37 |
| Waitlist Control (Survivors) | Change in Survivor Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | -0.10 Days | Standard Deviation 0.44 |
Secondary
Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report)
Number of cigarettes smoked in a typical day in past 2 weeks, as reported by survivor.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | -0.01 Cigarettes Per Day | Standard Deviation 0.05 |
| Supporter-Only CARE (Survivors) | Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | -1.05 Cigarettes Per Day | Standard Deviation 3.36 |
| Waitlist Control (Survivors) | Change in Survivor Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | -0.62 Cigarettes Per Day | Standard Deviation 2.62 |
Secondary
Change in Survivor Depression at 3 Months Post-baseline (Self Report)
Sum score on the Depression subscale of the Depression and Anxiety Stress Scales (DASS-21), completed by survivor in reference to past week. Range: 0 to 21; higher scores indicate greater depression.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Depression at 3 Months Post-baseline (Self Report) | -1.58 score on a scale | Standard Deviation 6.15 |
| Supporter-Only CARE (Survivors) | Change in Survivor Depression at 3 Months Post-baseline (Self Report) | -3.00 score on a scale | Standard Deviation 3.15 |
| Waitlist Control (Survivors) | Change in Survivor Depression at 3 Months Post-baseline (Self Report) | -2.52 score on a scale | Standard Deviation 4.57 |
Secondary
Change in Survivor Flourishing at 3 Months Post-baseline (Self Report)
Sum score on Flourishing Index Measure, completed by survivor. Range: 0 to 120; higher scores indicate more flourishing.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Flourishing at 3 Months Post-baseline (Self Report) | 0.21 score on a scale | Standard Deviation 16.7 |
| Supporter-Only CARE (Survivors) | Change in Survivor Flourishing at 3 Months Post-baseline (Self Report) | 2.89 score on a scale | Standard Deviation 12.43 |
| Waitlist Control (Survivors) | Change in Survivor Flourishing at 3 Months Post-baseline (Self Report) | -2.90 score on a scale | Standard Deviation 13.43 |
Secondary
Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of methamphetamine use in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report) | 0.16 Days | Standard Deviation 0.69 |
| Supporter-Only CARE (Survivors) | Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report) | 0.29 Days | Standard Deviation 1.31 |
| Waitlist Control (Survivors) | Change in Survivor Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report) | -0.19 Days | Standard Deviation 0.87 |
Secondary
Change in Survivor Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of non-prescription opioid use in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Analyses could not be performed because no participants reported non-prescription opioid use.
Secondary
Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report)
Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report) | 0.11 Days | Standard Deviation 0.46 |
| Supporter-Only CARE (Survivors) | Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report) | -0.05 Days | Standard Deviation 0.23 |
| Waitlist Control (Survivors) | Change in Survivor Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report) | 0.24 Days | Standard Deviation 1.09 |
Secondary
Change in Survivor Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report)
Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by survivor. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Analyses could not be performed because no participants reported opioid use.
Secondary
Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report)
Sum score on Work/School/Responsibility Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report) | -2.95 score on a scale | Standard Deviation 6.97 |
| Supporter-Only CARE (Survivors) | Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report) | -3.75 score on a scale | Standard Deviation 5.82 |
| Waitlist Control (Survivors) | Change in Survivor Role Impairment at 3 Months Post-baseline (Self Report) | -4.00 score on a scale | Standard Deviation 5.02 |
Secondary
Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report)
Sum score on Social Impairment subscale of the Behavioral Activation for Depression Scale (BADS), completed by survivor in reference to past week. Range: 0 to 30; higher scores indicate more impairment.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report) | -3.21 score on a scale | Standard Deviation 6.6 |
| Supporter-Only CARE (Survivors) | Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report) | -0.40 score on a scale | Standard Deviation 7.71 |
| Waitlist Control (Survivors) | Change in Survivor Social Impairment at 3 Months Post-baseline (Self Report) | -1.57 score on a scale | Standard Deviation 7.72 |
Secondary
Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report)
Number of typical drinking days per week in past month reported by survivor on the Daily Drinking Questionnaire. Range: 0 to 7.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | 0.32 days per week | Standard Deviation 1.6 |
| Supporter-Only CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | -0.40 days per week | Standard Deviation 0.99 |
| Waitlist Control (Survivors) | Change in Survivor Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | 0.25 days per week | Standard Deviation 1.65 |
Secondary
Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report)
Number of typical drinking hours per week in past month reported by survivor on the Daily Drinking Questionnaire.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | 1.32 hours per week | Standard Deviation 7.45 |
| Supporter-Only CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | -0.79 hours per week | Standard Deviation 3.87 |
| Waitlist Control (Survivors) | Change in Survivor Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | -1.95 hours per week | Standard Deviation 8.51 |
Secondary
Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report)
Number of typical drinks per week in past month reported by survivor on the Daily Drinking Questionnaire
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | 0.58 drinks per week | Standard Deviation 5.96 |
| Supporter-Only CARE (Survivors) | Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | -1.80 drinks per week | Standard Deviation 2.89 |
| Waitlist Control (Survivors) | Change in Survivor Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | -0.25 drinks per week | Standard Deviation 9.3 |
Secondary
Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report)
Sum score on the Significant Others' Responses to Trauma Scale (SORTS), completed by supporter in reference to the past month. Range: 0 to 112; higher scores indicate greater accommodation.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report) | 12.78 score on a scale | Standard Error 2.96 |
| Supporter-Only CARE (Survivors) | Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report) | 8.64 score on a scale | Standard Error 2.95 |
| Waitlist Control (Survivors) | Supporter Accommodation of Survivor PTSD Symptoms at 1 Month Post-baseline (Self Report) | 17.66 score on a scale | Standard Error 2.01 |
Secondary
Supporter Distress in Helping at 1 Month Post-baseline (Self Report)
Sum score on the Emotional Distress subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 24 to 120; higher scores indicate greater distress.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Distress in Helping at 1 Month Post-baseline (Self Report) | 53.59 score on a scale | Standard Error 2.82 |
| Supporter-Only CARE (Survivors) | Supporter Distress in Helping at 1 Month Post-baseline (Self Report) | 55.99 score on a scale | Standard Error 2.8 |
| Waitlist Control (Survivors) | Supporter Distress in Helping at 1 Month Post-baseline (Self Report) | 61.57 score on a scale | Standard Error 2.83 |
Secondary
Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report)
Sum score on the Confusion subscale of the Impact on Friends measure, completed by supporter in reference to the past month. Range: 6 to 30; higher scores indicate greater perceived ineffectiveness.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report) | 12.13 score on a scale | Standard Error 0.91 |
| Supporter-Only CARE (Survivors) | Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report) | 12.78 score on a scale | Standard Error 0.9 |
| Waitlist Control (Survivors) | Supporter Perceived Helping Ineffectiveness at 1 Month Post-baseline (Self Report) | 14.57 score on a scale | Standard Error 0.91 |
Secondary
Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report)
Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions.
Time frame: 1 month
Population: Only assessed among survivors reporting past-month disclosure to the supporter
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 8.56 score on a scale | Standard Error 1.02 |
| Supporter-Only CARE (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 9.53 score on a scale | Standard Error 0.85 |
| Waitlist Control (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Informant Report) | 8.56 score on a scale | Standard Error 1.02 |
Secondary
Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report)
Mean score on ratings of distress associated endorsed items on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by survivor in reference to supporter's reactions to survivor in past month. Range: 0 to 3; higher scores indicate more distress.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report) | 1.28 score on a scale | Standard Error 0.28 |
| Supporter-Only CARE (Survivors) | Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report) | 1.50 score on a scale | Standard Error 0.24 |
| Waitlist Control (Survivors) | Survivor Distress Associated With Supporter Negative Reactions at 1 Month Post-baseline (Self Report) | 1.37 score on a scale | Standard Error 0.23 |
Secondary
Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report)
Mean score on measure created for this study, completed by survivor. Range: 0 to 1; higher scores indicate greater participation.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 0.64 score on a scale | Standard Error 0.07 |
| Supporter-Only CARE (Survivors) | Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 0.49 score on a scale | Standard Error 0.07 |
| Waitlist Control (Survivors) | Survivor Participation in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 0.52 score on a scale | Standard Error 0.07 |
Secondary
Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report)
Sum score score on measure created for this study, completed by survivor. Range: 0 to 10; higher scores indicate greater willingness.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report) | -0.21 score on a scale | Standard Deviation 1.69 |
| Supporter-Only CARE (Survivors) | Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report) | 0.57 score on a scale | Standard Deviation 1.99 |
| Waitlist Control (Survivors) | Survivor Willingness to Participate in Criminal Justice Process at 1 Month Post-baseline (Self Report) | -0.19 score on a scale | Standard Deviation 1.33 |
Other Pre-specified
Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of cannabis use in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | 0.45 Days | Standard Deviation 1.88 |
| Supporter-Only CARE (Survivors) | Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | -0.11 Days | Standard Deviation 0.32 |
| Waitlist Control (Survivors) | Change in Supporter Cannabis Use Frequency at 3 Months Post-baseline (Self Report) | -0.85 Days | Standard Deviation 3.56 |
Other Pre-specified
Change in Supporter Cigarette Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of cigarette use in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments. It was not possible to compute change scores for the Supporter-only condition because no participants reported cigarette use.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | -0.10 Days | Standard Deviation 0.31 |
| Waitlist Control (Survivors) | Change in Supporter Cigarette Use Frequency at 3 Months Post-baseline (Self Report) | -0.15 Days | Standard Deviation 2.37 |
Other Pre-specified
Change in Supporter Cigarette Use Quantity at 3 Months Post-baseline (Self Report)
Number of cigarettes smoked in a typical day in past 2 weeks, as reported by supporter.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments. It was not possible to compute change scores for the Supporter-only condition because no participants reported cigarette use.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | -0.05 Cigarettes Per Day | Standard Deviation 0.22 |
| Waitlist Control (Survivors) | Change in Supporter Cigarette Use Quantity at 3 Months Post-baseline (Self Report) | -0.18 Cigarettes Per Day | Standard Deviation 1.16 |
Other Pre-specified
Change in Supporter Methamphetamine Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of methamphetamine use in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: It was not possible to compute change scores because no participants reported methamphetamine use at any assessment
Other Pre-specified
Change in Supporter Non-prescription Opioid Use Frequency at 3 Months Post-baseline (Self Report)
Number of days of non-prescription opioid use in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: It was not possible to compute change scores because no participants reported non-prescription opioid use at any assessment
Other Pre-specified
Change in Supporter Prescription Amphetamine Misuse Frequency at 3 Months Post-baseline (Self Report)
Number of days of prescription amphetamine use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: It was not possible to compute change scores because amphetamine use was very low base rate
Other Pre-specified
Change in Supporter Prescription Opioid Misuse Frequency at 3 Months Post-baseline (Self Report)
Number of days of prescription opioid use not as prescribed in past 2 weeks, as reported by supporter. Range: 0 to 14.
Time frame: Baseline, 3 months
Population: It was not possible to compute change scores because no participants reported prescription opioid use at any assessment
Other Pre-specified
Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report)
Number of typical drinking days per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | 0.05 Days Per Week | Standard Deviation 0.83 |
| Supporter-Only CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | -0.22 Days Per Week | Standard Deviation 0.69 |
| Waitlist Control (Survivors) | Change in Supporter Typical Alcohol Consumption (Frequency) at 3 Months Post-baseline (Self Report) | -0.21 Days Per Week | Standard Deviation 1.32 |
Other Pre-specified
Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report)
Number of typical drinking hours per week in past month reported by supporter on the Daily Drinking Questionnaire.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | 2.30 Hours Per Week | Standard Deviation 8.9 |
| Supporter-Only CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | -0.89 Hours Per Week | Standard Deviation 2.03 |
| Waitlist Control (Survivors) | Change in Supporter Typical Alcohol Consumption (Hours) at 3 Months Post-baseline (Self Report) | -1.26 Hours Per Week | Standard Deviation 7.09 |
Other Pre-specified
Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report)
Number of typical drinks per week in past month reported by supporter on the Daily Drinking Questionnaire. Range: 0 to 7.
Time frame: Baseline, 3 months
Population: Because this is a change score, participants were excluded listwise if they had missing data at one or both assessments.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | 0.25 Drinks Per Week | Standard Deviation 2.59 |
| Supporter-Only CARE (Survivors) | Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | -0.78 Drinks Per Week | Standard Deviation 1.48 |
| Waitlist Control (Survivors) | Change in Supporter Typical Alcohol Consumption (Quantity) at 3 Months Post-baseline (Self Report) | -1.87 Drinks Per Week | Standard Deviation 5.99 |
Other Pre-specified
Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report)
Sum score on Negative Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 48; higher scores indicate more frequent negative reactions.
Time frame: 1 month
Population: Only assessed among supporters reporting past-month receipt of disclosure from the survivor
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 2.22 score on a scale | Standard Deviation 3.12 |
| Supporter-Only CARE (Survivors) | Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 1.79 score on a scale | Standard Deviation 2.2 |
| Waitlist Control (Survivors) | Supporter Negative Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 4.19 score on a scale | Standard Deviation 3.62 |
Other Pre-specified
Supporter Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report)
Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 10.35 score on a scale | Standard Deviation 1.84 |
| Supporter-Only CARE (Survivors) | Supporter Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 10.45 score on a scale | Standard Deviation 1.76 |
Other Pre-specified
Supporter Perceived Impact of Intervention at 1 Month Post-baseline (Self-report)
Sum score on survey created for this study, completed by supporter. Range: 4 to 20; higher scores indicate greater perceived impact of intervention.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 16.80 score on a scale | Standard Deviation 2.53 |
| Supporter-Only CARE (Survivors) | Supporter Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 16.60 score on a scale | Standard Deviation 2.19 |
Other Pre-specified
Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report)
Sum score on Positive Reactions subscale of the Social Reactions Questionnaire - Shortened, completed by supporter in reference to supporter's reactions to survivor in past month. Range: 0 to 16; higher scores indicate more frequent positive reactions.
Time frame: 1 month
Population: Only assessed among supporters reporting past-month receipt of disclosure from the survivor
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 8.56 score on a scale | Standard Error 0.63 |
| Supporter-Only CARE (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 8.74 score on a scale | Standard Error 0.69 |
| Waitlist Control (Survivors) | Supporter Positive Reactions to Disclosure at 1 Month Post-baseline (Self Report) | 9.36 score on a scale | Standard Error 0.99 |
Other Pre-specified
Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report)
Single item representing frequency of survivor's disclosures to supporter in past month, completed by supporter, adapted from the Early Intervention Clinic Disclosure Scale. Participants were instructed to enter a numerical value corresponding to number of disclosures. Higher scores indicate more frequent disclosure.
Time frame: 1 month
Population: Participants were excluded if they did not complete this item.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report) | 2.56 disclosures | Standard Error 0.21 |
| Supporter-Only CARE (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report) | 2.70 disclosures | Standard Error 0.21 |
| Waitlist Control (Survivors) | Survivor Disclosure Frequency to Supporter at 1 Month Post-baseline (Informant Report) | 2.02 disclosures | Standard Error 0.2 |
Other Pre-specified
Survivor Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report)
Sum score on survey created for this study, completed by survivor. Range: 4 to 16; higher scores indicate greater perceived cultural responsiveness of intervention.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 9.84 score on a scale | Standard Deviation 1.74 |
| Supporter-Only CARE (Survivors) | Survivor Perceived Cultural Responsiveness of Intervention at 1 Month Post-baseline (Self Report) | 10.19 score on a scale | Standard Deviation 1.99 |
Other Pre-specified
Survivor Perceived Impact of Intervention at 1 Month Post-baseline (Self-report)
Sum score on survey created for this study, completed by survivor. Range: 4 to 20; higher scores indicate greater perceived impact of intervention.
Time frame: 1 month
Population: Participants were excluded if they did not complete this scale.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Dyadic CARE (Survivors) | Survivor Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 16.56 score on a scale | Standard Deviation 2.5 |
| Supporter-Only CARE (Survivors) | Survivor Perceived Impact of Intervention at 1 Month Post-baseline (Self-report) | 15.71 score on a scale | Standard Deviation 2.37 |